Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-03 11:02 am Sale | 13G | Esperion Therapeutics Inc. ESPR | Meditor Group Ltd | 3,791,300 3.300% | -677,535 (-15.16%) | View |
| 2023-01-04 2:30 pm Unchanged | 13G | Esperion Therapeutics Inc. ESPR | Meditor Group Ltd | 4,468,835 6.100% | 0 (Unchanged) | View |
| 2022-01-12 2:15 pm Purchase | 13G | Esperion Therapeutics Inc. ESPR | Meditor Group Ltd | 4,468,835 7.100% | 1,789,000 (+66.76%) | View |
| 2021-01-06 2:37 pm Unchanged | 13G | Esperion Therapeutics Inc. ESPR | Meditor Group Ltd | 2,679,835 9.600% | 0 (Unchanged) | View |
| 2020-01-06 08:23 am Unchanged | 13G | Esperion Therapeutics Inc. ESPR | Meditor Group Ltd | 2,679,835 9.900% | 0 (Unchanged) | View |